United States · FDA National Drug Code directory
Haloperidol decanoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70710-1464_b06b16a2-177a-4bd6-b1fa-80d1be6acfb8
- Product NDC
- 70710-1464
- Form
- INJECTION
- Composition / generic term
- Haloperidol decanoate
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191114
- Source listing expiry
- 20271231
Source-listed ingredients
- HALOPERIDOL DECANOATE — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (70710-1464-1) / 5 mL in 1 VIAL, MULTI-DOSE · 70710-1464-1
- 5 VIAL, MULTI-DOSE in 1 CARTON (70710-1464-5) / 5 mL in 1 VIAL, MULTI-DOSE · 70710-1464-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →